Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

Remel Shigella sonnei Phase 1 & 2 Agglutinating Serum Recalled by Remel Inc Due to The serum may fail to agglutinate within the...

Date: December 8, 2017
Company: Remel Inc
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Remel Inc directly.

Affected Products

Remel Shigella sonnei Phase 1 & 2 Agglutinating Serum, Ref R30164201 ZH01. Product Usage: Suitable for the use in slide agglutination tests to identify Shigella cultures presumptively for epidemiological and diagnostic purposes.

Quantity: 237 units (single bottles)

Why Was This Recalled?

The serum may fail to agglutinate within the specified minimum reaction time.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Remel Inc

Remel Inc has 70 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report